FDA has agreed to review Gliatech's ADCON-P....

• Messages sorted by: [ date ][ thread ][ subject ][ author ]
• Next message: Helen Dynda: "April 20, 2000 -- Gliatech Submits ADCON-P Module To FDA...."
• Previous message: Helen Dynda: "Re: Angel Flight --- No financially-needy patient is denied access to.........."

http://www.gliatech.com/news/newsread.cfm?ID=192

Gliatech's ADCON-P is a proprietary, resorbable, carbohydrate polymer liquid designed to inhibit postsurgical scarring and adhesions following gynecological pelvic surgery. The company is conducting a pivotal trial for ADCON-P at approximately 20 sites and in more than 200 patients undergoing minimally invasive gynecological surgery.

• Next message: Helen Dynda: "April 20, 2000 -- Gliatech Submits ADCON-P Module To FDA...."
• Previous message: Helen Dynda: "Re: Angel Flight --- No financially-needy patient is denied access to.........."